Citation Impact
Citing Papers
High-throughput characterization of protein–protein interactions by reprogramming yeast mating
2017 StandoutNobel
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Arginine, arginine analogs and nitric oxide production in chronic kidney disease
2006
A community effect in animal development
1988 StandoutNatureNobel
Delivery of molecular and cellular medicine to solid tumors
1998
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Efficient Generation of Functional Hepatocytes From Human Embryonic Stem Cells and Induced Pluripotent Stem Cells by HNF4α Transduction
2011
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
2006
Endocytosis and Lysosomal Targeting of Epidermal Growth Factor Receptors Are Mediated by Distinct Sequences Independent of the Tyrosine Kinase Domain
1995
Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer
2001
Fine Epitope Mapping of anti-Epidermal Growth Factor Receptor Antibodies Through Random Mutagenesis and Yeast Surface Display
2004
Endothelial cell regulation by transforming growth factor‐beta
1991
Heterogeneity of Endothelial Cells
1999
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Design of biologically active binary protein 2D materials
2021 StandoutNatureNobel
Inhibition of Vascular Endothelial Growth Factor (VEGF)-induced Endothelial Cell Proliferation by a Peptide Corresponding to the Exon 7-Encoded Domain of VEGF165
1997
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
2012 StandoutNobel
B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40
1993 StandoutNatureNobel
HIV infection does not require endocytosis of its receptor, CD4
1988 StandoutNobel
Diverse Requirements for Microglial Survival, Specification, and Function Revealed by Defined-Medium Cultures
2017
Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling
2017 StandoutNatureNobel
An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors
2003
Ligand-targeted therapeutics in anticancer therapy
2002
Neuronal nicotinic receptors: from structure to pathology
2004
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
2002
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Bispecific Designed Ankyrin Repeat Proteins (DARPins) Targeting Epidermal Growth Factor Receptor Inhibit A431 Cell Proliferation and Receptor Recycling
2011
TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
1993 StandoutNobel
The C-terminus of the S. cerevisiae α-pheromone receptor mediates an adaptive response to pheromone
1988 StandoutNobel
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
2011
Arming antibodies: prospects and challenges for immunoconjugates
2005
The LDL Receptor Gene: A Mosaic of Exons Shared with Different Proteins
1985 StandoutScienceNobel
Transport of Molecules, Particles, and Cells in Solid Tumors
1999
Inhibition of the apparent affinity of the epidermal growth factor receptor caused by phorbol diesters correlates with phosphorylation of threonine-654 but not other sites on the receptor
1986
Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication.
1988
Active site and complete sequence of the suicidal methyltransferase that counters alkylation mutagenesis.
1985 StandoutNobel
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
1987 StandoutScience
Production of an Epidermal Growth Factor Receptor-Related Protein
1984 Science
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
1984 StandoutNature
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
1997 Standout
Isolation and characterization of Caenorhabditis elegans DNA sequences homologous to the v-abl oncogene.
1986 StandoutNobel
Identification of two anti-parallel beta-sheet conformations in the solution structure of murine epidermal growth factor by proton magnetic resonance.
1986 StandoutNobel
Genetic determinants of neoplastic transformation by the retroviral oncogene v-erbB.
1988 StandoutNobel
Conversion of low-affinity interleukin 2 receptors to a high-affinity state following fusion of cell membranes.
1986
Regulation of transmembrane signaling by receptor phosphorylation
1987 StandoutNobel
Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms
1986
Phorbol esters promote alpha 1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism.
1985 StandoutNobel
Autocrine growth factors and cancer
1985 Nature
Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor.
1995 StandoutNobel
Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain
1985 StandoutNobel
Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor.
1985
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
1985
Molecular basis for two different affinity states of the interleukin 2 receptor: affinity conversion model.
1986 StandoutNobel
Location of the active site for enzyme-adenylate formation in DNA ligases.
1991 StandoutNobel
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
1992 StandoutScience
Epidermal growth factor stimulates glycogen synthase activity in cultured cells.
1985
Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches
2013 StandoutNobel
Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells
2012 StandoutNobel
Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen.
1983
A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA
1985 StandoutNobel
Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor
1986
Expression of functional human interleukin-2 receptor in mouse T cells by cDNA transfection
1986 StandoutNatureNobel
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor.
1987 StandoutNobel
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines.
1989 StandoutNobel
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
1987 Standout
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
1984 StandoutNature
The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
1984 StandoutNobel
Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells
2001 StandoutNobel
C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity.
1984
Domain map of the LDL receptor: Sequence homology with the epidermal growth factor precursor
1984 StandoutNobel
Epidermal growth factor and potent phorbol tumor promoters induce epidermal growth factor receptor phosphorylation in a similar but distinctively different manner in human epidermoid carcinoma A431 cells.
1984
Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.
1984
Genes Expressed in Human Tumor Endothelium
2000 StandoutScience
Solution structure of murine epidermal growth factor: determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry.
1987 StandoutNobel
Effects of protein kinase C activation after epidermal growth factor binding on epidermal growth factor receptor phosphorylation.
1986
Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors.
1988
Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.
1991
Molecular cloning of cDNA encoding human interleukin-2 receptor
1984 StandoutNatureNobel
Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.
1984
Cassette of Eight Exons Shared by Genes for LDL Receptor and EGF Precursor
1985 StandoutScienceNobel
Structural organization of the human insulin receptor ectodomain
1992
Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast
2005
Stimulation of protein phosphatase activity by insulin and growth factors in 3T3 cells.
1988 StandoutNobel
Angiogenesis.
1992 Standout
Works of Jun Sato being referenced
Effect of nicotine on the intimal hyperplasia after endothelial removal of the rabbit carotid artery
1997
Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L‐arginine in regenerated endothelial cells
1995
Bifunctional effects of transforming growth factor-β (TGF-β) on endothelial cell growth correlate with phenotypes of TGF-β binding sites
1990
Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium
2008
Human Epidermal Growth Factor (EGF) Receptor Sequence Recognized by EGF Competitive Monoclonal Antibodies
1989
Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors.
1991
Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier.
1992
Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells.
1996
Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.
1983
Human epidermal growth factor receptor residue covalently cross-linked to epidermal growth factor.
1990
Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier.
1995
Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.
1991
Media for Culture of Mammalian Cells
1998
Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity.
1984